Literature DB >> 2301441

Prevalence of thyroid abnormalities in patients with dermatitis herpetiformis and in control subjects with HLA-B8/-DR3.

A A Gaspari1, C M Huang, R J Davey, C Bondy, T J Lawley, S I Katz.   

Abstract

PURPOSE: The prevalence of thyroid dysfunction as measured by the presence of overt thyroid disease, abnormal results of thyroid function tests, or antithyroid antibodies was compared in patients with dermatitis herpetiformis (DH) and a normal control group who had the HLA-B8/-DR3 haplotype. PATIENTS AND METHODS: The study population consisted of 56 patients with DH and 26 control subjects with the HLA-B8/-DR3 haplotype. All were examined for thyroid function abnormalities and thyroid autoantibodies.
RESULTS: Patients with DH had a statistically significant increase in the prevalence of abnormal thyroid function test results and autoantibodies: 32% versus 4% for controls (Z = 2.01, p less than 0.02). In patients with DH, hypothyroidism was the most common thyroid abnormality (12 of 56) followed by hyperthyroidism (four of 56). Two patients had normal thyroid function test results with thyroid autoantibodies. Risk factors for thyroid abnormalities in patients with DH were increasing age (chi 2 = 6.55, p less than 0.02, significant) and the presence of thyroid microsomal antibodies. The HLA-B8/-DR3 haplotype was not a risk factor for thyroid abnormalities.
CONCLUSION: The findings suggest that thyroid disease is independently associated with DH. Examination of patients with DH should include thyroid function tests along with assays for antithyroid antibodies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2301441     DOI: 10.1016/0002-9343(90)90464-o

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  5 in total

1.  Remission in dermatitis herpetiformis: a cohort study.

Authors:  So Yeon Paek; Seth M Steinberg; Stephen I Katz
Journal:  Arch Dermatol       Date:  2010-11-15

2.  A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice.

Authors:  Eric Marietta; Kay Black; Michael Camilleri; Patricia Krause; Roy S Rogers; Chella David; Mark R Pittelkow; Joseph A Murray
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

3.  Abnormal thyroid function test results in patients with Fisher-Evans syndrome.

Authors:  S Lio; M Albin; G Girelli; M P Perrone; G Gandolfo; L Conti; D Mazzone; M D'Armiento
Journal:  J Endocrinol Invest       Date:  1993-03       Impact factor: 4.256

Review 4.  Current Concepts of Dermatitis Herpetiformis.

Authors:  Teea Salmi; Kaisa Hervonen
Journal:  Acta Derm Venereol       Date:  2020-02-12       Impact factor: 3.875

5.  Dermatitis herpetiformis: pathophysiology, clinical presentation, diagnosis and treatment.

Authors:  Marcos Vinícius Clarindo; Adriana Tomazzoni Possebon; Emylle Marlene Soligo; Hirofumi Uyeda; Roseli Terezinha Ruaro; Julio Cesar Empinotti
Journal:  An Bras Dermatol       Date:  2014 Nov-Dec       Impact factor: 1.896

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.